Cell and Gene Therapy Manufacturing Services Market, Global Outlook and Forecast 2024-2031

Report ID: 1647775 | Published Date: Oct 2024 | No. of Page: 110 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Cell and Gene Therapy Manufacturing Services Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cell and Gene Therapy Manufacturing Services Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing Services Overall Market Size
    2.1 Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028
    2.2 Global Cell and Gene Therapy Manufacturing Services Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cell and Gene Therapy Manufacturing Services Players in Global Market
    3.2 Top Global Cell and Gene Therapy Manufacturing Services Companies Ranked by Revenue
    3.3 Global Cell and Gene Therapy Manufacturing Services Revenue by Companies
    3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing Services Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Cell and Gene Therapy Manufacturing Services Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Players in Global Market
        3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Cell and Gene Therapy Manufacturing Services Market Size Markets, 2021 & 2028
        4.1.2 Allogeneic
        4.1.3 Autologous
        4.1.4 Viral Vector
    4.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
        4.2.1 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
        4.2.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
        4.2.3 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
        5.1.2 Oncology Diseases
        5.1.3 Cardiovascular Diseases
        5.1.4 Orthopedic Diseases
        5.1.5 Ophthalmology Diseases
        5.1.6 Infectious Diseases
        5.1.7 Others
    5.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
        5.2.1 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
        5.2.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
        5.2.3 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
    6.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
        6.2.1 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
        6.2.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
        6.2.3 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
        6.3.2 US Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.3.3 Canada Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.3.4 Mexico Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
        6.4.2 Germany Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.3 France Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.4 U.K. Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.5 Italy Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.6 Russia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.4.8 Benelux Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
        6.5.2 China Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.5.3 Japan Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.5.4 South Korea Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.5.6 India Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
        6.6.2 Brazil Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.6.3 Argentina Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
        6.7.2 Turkey Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.7.3 Israel Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
        6.7.5 UAE Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
7 Players Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Corporate Summary
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.1.5 Thermo Fisher Scientific Key News
    7.2 Merck KGaA
        7.2.1 Merck KGaA Corporate Summary
        7.2.2 Merck KGaA Business Overview
        7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.2.5 Merck KGaA Key News
    7.3 Charles River Laboratories
        7.3.1 Charles River Laboratories Corporate Summary
        7.3.2 Charles River Laboratories Business Overview
        7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.3.5 Charles River Laboratories Key News
    7.4 Lonza
        7.4.1 Lonza Corporate Summary
        7.4.2 Lonza Business Overview
        7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.4.5 Lonza Key News
    7.5 Catalent
        7.5.1 Catalent Corporate Summary
        7.5.2 Catalent Business Overview
        7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.5.5 Catalent Key News
    7.6 WuXi AppTec
        7.6.1 WuXi AppTec Corporate Summary
        7.6.2 WuXi AppTec Business Overview
        7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.6.5 WuXi AppTec Key News
    7.7 Takara Bio Inc
        7.7.1 Takara Bio Inc Corporate Summary
        7.7.2 Takara Bio Inc Business Overview
        7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.7.5 Takara Bio Inc Key News
    7.8 Nikon Corporation
        7.8.1 Nikon Corporation Corporate Summary
        7.8.2 Nikon Corporation Business Overview
        7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.8.5 Nikon Corporation Key News
    7.9 FUJIFILM Holdings Corporation
        7.9.1 FUJIFILM Holdings Corporation Corporate Summary
        7.9.2 FUJIFILM Holdings Corporation Business Overview
        7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.9.5 FUJIFILM Holdings Corporation Key News
    7.10 F. Hoffmann-La Roche
        7.10.1 F. Hoffmann-La Roche Corporate Summary
        7.10.2 F. Hoffmann-La Roche Business Overview
        7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.10.5 F. Hoffmann-La Roche Key News
    7.11 Oxford Biomedica Plc
        7.11.1 Oxford Biomedica Plc Corporate Summary
        7.11.2 Oxford Biomedica Plc Business Overview
        7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.11.5 Oxford Biomedica Plc Key News
    7.12 Cell and Gene Therapy Catapult
        7.12.1 Cell and Gene Therapy Catapult Corporate Summary
        7.12.2 Cell and Gene Therapy Catapult Business Overview
        7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.12.5 Cell and Gene Therapy Catapult Key News
    7.13 The Discovery Labs LLC
        7.13.1 The Discovery Labs LLC Corporate Summary
        7.13.2 The Discovery Labs LLC Business Overview
        7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.13.5 The Discovery Labs LLC Key News
    7.14 RoslinCT
        7.14.1 RoslinCT Corporate Summary
        7.14.2 RoslinCT Business Overview
        7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.14.5 RoslinCT Key News
    7.15 JRS PHARMA
        7.15.1 JRS PHARMA Corporate Summary
        7.15.2 JRS PHARMA Business Overview
        7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.15.5 JRS PHARMA Key News
    7.16 FinVector
        7.16.1 FinVector Corporate Summary
        7.16.2 FinVector Business Overview
        7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.16.5 FinVector Key News
    7.17 ABL
        7.17.1 ABL Corporate Summary
        7.17.2 ABL Business Overview
        7.17.3 ABL Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.17.5 ABL Key News
    7.18 Resilience
        7.18.1 Resilience Corporate Summary
        7.18.2 Resilience Business Overview
        7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.18.5 Resilience Key News
    7.19 BioCentriq
        7.19.1 BioCentriq Corporate Summary
        7.19.2 BioCentriq Business Overview
        7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.19.5 BioCentriq Key News
    7.20 Porton Biopharma Limited
        7.20.1 Porton Biopharma Limited Corporate Summary
        7.20.2 Porton Biopharma Limited Business Overview
        7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.20.5 Porton Biopharma Limited Key News
    7.21 Andelyn Biosciences
        7.21.1 Andelyn Biosciences Corporate Summary
        7.21.2 Andelyn Biosciences Business Overview
        7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.21.5 Andelyn Biosciences Key News
    7.22 Commercializing Living Therapies
        7.22.1 Commercializing Living Therapies Corporate Summary
        7.22.2 Commercializing Living Therapies Business Overview
        7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.22.5 Commercializing Living Therapies Key News
    7.23 Vibalogics
        7.23.1 Vibalogics Corporate Summary
        7.23.2 Vibalogics Business Overview
        7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.23.5 Vibalogics Key News
    7.24 Anemocyte Srl
        7.24.1 Anemocyte Srl Corporate Summary
        7.24.2 Anemocyte Srl Business Overview
        7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.24.5 Anemocyte Srl Key News
    7.25 ElevateBio
        7.25.1 ElevateBio Corporate Summary
        7.25.2 ElevateBio Business Overview
        7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Major Product Offerings
        7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
        7.25.5 ElevateBio Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Cell and Gene Therapy Manufacturing Services Market Opportunities & Trends in Global Market
    Table 2. Cell and Gene Therapy Manufacturing Services Market Drivers in Global Market
    Table 3. Cell and Gene Therapy Manufacturing Services Market Restraints in Global Market
    Table 4. Key Players of Cell and Gene Therapy Manufacturing Services in Global Market
    Table 5. Top Cell and Gene Therapy Manufacturing Services Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cell and Gene Therapy Manufacturing Services Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cell and Gene Therapy Manufacturing Services Product Type
    Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
    Table 30. Thermo Fisher Scientific Corporate Summary
    Table 31. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 32. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 33. Merck KGaA Corporate Summary
    Table 34. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 35. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 36. Charles River Laboratories Corporate Summary
    Table 37. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 38. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 39. Lonza Corporate Summary
    Table 40. Lonza Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 41. Lonza Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 42. Catalent Corporate Summary
    Table 43. Catalent Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 44. Catalent Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 45. WuXi AppTec Corporate Summary
    Table 46. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 47. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 48. Takara Bio Inc Corporate Summary
    Table 49. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 50. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 51. Nikon Corporation Corporate Summary
    Table 52. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 53. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 54. FUJIFILM Holdings Corporation Corporate Summary
    Table 55. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 56. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 57. F. Hoffmann-La Roche Corporate Summary
    Table 58. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 59. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 60. Oxford Biomedica Plc Corporate Summary
    Table 61. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 62. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 63. Cell and Gene Therapy Catapult Corporate Summary
    Table 64. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 65. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 66. The Discovery Labs LLC Corporate Summary
    Table 67. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 68. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 69. RoslinCT Corporate Summary
    Table 70. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 71. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 72. JRS PHARMA Corporate Summary
    Table 73. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 74. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 75. FinVector Corporate Summary
    Table 76. FinVector Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 77. FinVector Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 78. ABL Corporate Summary
    Table 79. ABL Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 80. ABL Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 81. Resilience Corporate Summary
    Table 82. Resilience Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 83. Resilience Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 84. BioCentriq Corporate Summary
    Table 85. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 86. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 87. Porton Biopharma Limited Corporate Summary
    Table 88. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 89. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 90. Andelyn Biosciences Corporate Summary
    Table 91. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 92. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 93. Commercializing Living Therapies Corporate Summary
    Table 94. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 95. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 96. Vibalogics Corporate Summary
    Table 97. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 98. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 99. Anemocyte Srl Corporate Summary
    Table 100. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 101. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
    Table 102. ElevateBio Corporate Summary
    Table 103. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offerings
    Table 104. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cell and Gene Therapy Manufacturing Services Segment by Type in 2021
    Figure 2. Cell and Gene Therapy Manufacturing Services Segment by Application in 2021
    Figure 3. Global Cell and Gene Therapy Manufacturing Services Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2021
    Figure 8. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 12. US Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 16. Germany Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 24. China Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 30. Brazil Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
    Figure 33. Turkey Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
    Figure 37. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Lonza Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Catalent Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. FinVector Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. ABL Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Resilience Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
110
Frequently Asked Questions
Cell and Gene Therapy Manufacturing Services Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell and Gene Therapy Manufacturing Services Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell and Gene Therapy Manufacturing Services Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports